Territorial Availability: Available through Bertin Technologies only in France
- Synonyms
- 2-[(3-chloro-2-methylphenyl)amino]-benzoic acid
- Correlated keywords
- clotam GEA 6414 GEA6414 migea tolfedine folfenamate tolfine anthranilic acid COX1 COX2 DH-82 A-23187 Sp 1 34 PANC1 L36pl PANC28 MDAMB231
- Product Overview:
Tolfenamic acid is a non-steroidal anti-inflammatory drug (NSAID) with anticancer activity.{52184,1819,52185,52186,52187} It is selective for COX-2 over COX-1 in canine DH82 monocyte/macrophage cells (IC50s = 3.53 and >51.2 ?g/ml, respectively).{52184} Tolfenamic acid inhibits calcium influx in human polymorphonuclear leukocytes (PMNLs) induced by N-formyl-L-methionyl-L-leucyl-L-phenylalanine (fMLP; Item No. 21495) or the calcium ionophore A23187 (Item Nos. 11016 | 22030) in a concentration-dependent manner.{1819} It decreases protein levels of the transcription factors Sp1, Sp3, and Sp4 in PANC-1 and L3.6pl cells when used at a concentration of 50 ?M and inhibits proliferation of PANC-1, L3.6pl, and PANC-28 cells in a concentration-dependent manner.{52186} Tolfenamic acid (50 and 100 ?M) decreases the viability of and induces apoptosis in MDA-MB-231 cells.{52187} It reduces tumor growth in an MDA-MB-231 mouse xenograft model when administered at doses of 25 and 50 mg/kg. Tolfenamic acid (150 ?mol/kg) reduces carrageenan-induced paw edema in mice by 24%.{52185}
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.